ADPT Adaptive Biotechnologies Corporation - Common Stock

NASDAQ · Life Sciences Tools & Services · Visualizza su SEC EDGAR ↗

$13,16

Prezzo · Mag 20, 2026

Fondamentali al Mag 5, 2026

Margine di Profitto Netto

-21.5%

ADPT Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

Prezzo

$13.16

Capitalizzazione di Mercato

$2.50B

P/E (TTM)

-41.6

EPS (TTM)

$-0.39

Ricavi (TTM)

$277M

Rendimento div.

—

ROE

-28.2%

D/E Debito/Patrimonio

0.6

Intervallo 52 sett.

$9 – $21

ADPT Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Ricavi e Utile Netto $277M

2017-12-31 → 2025-12-31

EPS $-0.39

2020-12-31 → 2025-12-31

Flusso di cassa libero $-49M

2019-12-31 → 2025-12-31

Margini -21.5%

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica

Tendenza 5 anni

ADPT

Mediana dei peer

P/E (TTM)

-41.6

28.9

P/S (TTM)

9.0

4.4

P/B

11.4

3.0

EV / EBITDA

-44.8

—

Price / FCF (Prezzo / FCF)

-51.0

—

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica

Tendenza 5 anni

ADPT

Mediana dei peer

Operating Margin (Margine Operativo)

-20.6%

—

Net Profit Margin (Margine di Profitto Netto)

-21.5%

-8.1%

ROA

-11.3%

-3.6%

ROE

-28.2%

-4.5%

ROIC

-16.3%

—

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica

Tendenza 5 anni

ADPT

Mediana dei peer

Debt / Equity (Debito / Patrimonio Netto)

0.6

36.5

Current Ratio (Rapporto corrente)

3.3

3.9

Quick Ratio

1.3

—

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica

Tendenza 5 anni

ADPT

Mediana dei peer

Revenue YoY (Ricavi YoY)

54.8%

—

Revenue CAGR 3Y (CAGR Ricavi 3Y)

14.3%

—

Revenue CAGR 5Y (CAGR Ricavi 5Y)

23.0%

—

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica

Tendenza 5 anni

ADPT

Mediana dei peer

EPS (Diluted) (EPS (Diluito))

$-0.39

—

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica

Tendenza 5 anni

ADPT

Mediana dei peer

ADPT Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

COMPRA 14 analisti

Acquisto forte 5 35,7%
Compra 7 50,0%
Mantieni 2 14,3%
Vendi 0 0,0%
Vendita forte 0 0,0%

Target Price a 12 Mesi

7 analisti · 2026-05-20

Mediana $20.00

← Sotto tutti i target $13.16

Basso $18.00

Alto $22.00

Target mediano $20.00 +52,0%

Target medio $20.14 +53,1%

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Sorpresa media

0.10%

Periodo	EPS Actual	EPS Stimato	Sorpresa
31 Marzo 2026	$-0.12	$-0.16	0.04%
31 Dicembre 2025	$-0.09	$-0.18	0.09%
30 Settembre 2025	$0.06	$-0.15	0.21%
30 Giugno 2025	$-0.17	$-0.24	0.07%
31 Marzo 2025	$-0.20	$-0.30	0.10%

Confronto tra pari Metriche chiave rispetto ai pari del settore

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
ADPT	$2.50B	-41.6	54.8%	-21.5%	-28.2%	—
BRKR	$7.17B	-314.1	2.1%	-0.25%	-0.40%	45.9%
RGEN	$9.23B	190.5	16.4%	6.6%	2.4%	—
AVTR	$7.82B	-14.7	-3.4%	-8.1%	-8.9%	32.6%
SHC	$5.02B	65.3	5.7%	6.7%	14.0%	55.5%
TXG	$2.08B	-46.6	5.2%	-6.8%	-5.5%	69.0%
ALMR	—	—	—	—	—	—
FTRE	$1.61B	-1.6	1.0%	-36.2%	-171.1%	—
BLFS	—	-241.8	28.9%	—	—	—
MRVI	—	-3.6	-28.3%	-70.4%	-48.6%	18.3%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Conto Economico 15

Dati annuali Conto Economico per ADPT
Metrica	2025	2024	2023	2022	2021	2020	2019	2018
Revenue	$277M	$179M	$170M	$185M	$154M	$98M	$85M	$56M
Cost of Revenue	$71M	$72M	$76M	$58M	$49M	$23M	$22M	$20M
R&D Expense	$94M	$103M	$122M	$142M	$142M	$116M	$71M	$39M
SG&A Expense	$73M	$73M	$84M	$89M	$75M	$50M	$30M	$20M
Operating Expenses	$334M	$342M	$397M	$385M	$363M	$251M	$163M	$105M
Operating Income	$-57M	$-163M	$-227M	$-200M	$-209M	$-153M	$-78M	$-50M
Interest Expense	$12M	$12M	$14M	$4M	·	·	·	·
Pretax Income	$-59M	$-160M	$-225M	$-200M	$-207M	$-146M	$-69M	·
Income Tax	$0	$0	$0	·	·	·	$0	·
Net Income	$-59M	$-159M	$-225M	$-200M	$-207M	$-146M	$-69M	$-46M
EPS (Basic)	$-0.39	$-1.08	$-1.56	$-1.40	$-1.48	$-1.11	·	·
EPS (Diluted)	$-0.39	$-1.08	$-1.56	$-1.40	$-1.48	$-1.11	·	·
Shares (Basic)	151,721,939	147,101,648	144,383,294	142,515,917	140,354,915	131,216,468	·	·
Shares (Diluted)	151,721,939	147,101,648	144,383,294	142,515,917	140,354,915	131,216,468	·	·
EBITDA	$-57M	$-163M	$-227M	$-200M	$-209M	$-153M	$-78M	·

Stato Patrimoniale 27

Dati annuali Stato Patrimoniale per ADPT
Metrica	2025	2024	2023	2022	2021	2020	2019	2018
Cash & Equivalents	$70M	$48M	$65M	$90M	$139M	$123M	$97M	$55M
Receivables	$50M	$42M	$38M	$40M	$17M	$10M	$13M	$5M
Inventory	$10M	$8M	$14M	$14M	$19M	$14M	$9M	$8M
Prepaid Expense	$13M	$11M	$11M	$9M	$13M	$15M	$14M	$3M
Current Assets	$300M	$284M	$410M	$562M	$403M	$727M	$613M	$181M
PP&E (Net)	$34M	$49M	$68M	$83M	$85M	$40M	$60M	$19M
PP&E (Gross)	$130M	$136M	$141M	$138M	$121M	$64M	$78M	$32M
Accum. Depreciation	$96M	$88M	$73M	$54M	$36M	$24M	$18M	$12M
Goodwill	$119M	$119M	$119M	$119M	$119M	$119M	$119M	$119M
Intangibles	$2M	$3M	$5M	$7M	$9M	$10M	$12M	$14M
Other Non-current Assets	$1M	$2M	$4M	$2M	$875.0K	$598.0K	$784.0K	$186.0K
Total Assets	$513M	$539M	$661M	$857M	$923M	$1.12B	$912M	$333M
Accounts Payable	$6M	$7M	$8M	$8M	$3M	$3M	$4M	$2M
Accrued Liabilities	$8M	$8M	$9M	$12M	$9M	$13M	$4M	$3M
Current Liabilities	$90M	$98M	$88M	$110M	$114M	$105M	$78M	$23M
Capital Leases	$70M	$79M	$89M	$99M	$107M	$104M	·	·
Other Non-current Liabilities	$20.0K	$20.0K	·	·	·	·	$93.0K	·
Total Liabilities	$288M	$337M	$353M	$393M	$319M	$373M	$341M	$30M
Long-term Debt	$131M	$133M	·	·	·	·	·	·
Total Debt	$131M	$133M	$131M	·	·	·	·	·
Common Stock	$15.0K	$14.0K	$14.0K	$14.0K	$14.0K	$14.0K	$12.0K	$1.0K
Paid-in Capital	$1.58B	$1.51B	$1.45B	$1.39B	$1.32B	$1.25B	$936M	$38M
Retained Earnings	$-1.36B	$-1.30B	$-1.14B	$-919M	$-719M	$-512M	$-365M	$-296M
AOCI	$253.0K	$166.0K	$215.0K	$-4M	$-1M	$893.0K	$671.0K	$-107.0K
Stockholders' Equity	$219M	$203M	$308M	$464M	$604M	$743M	$571M	$-258M
Liabilities + Equity	$513M	$539M	$661M	$857M	$923M	$1.12B	$912M	$333M
Shares Outstanding	153,779,418	147,773,744	145,082,271	143,105,002	141,393,865	137,646,896	125,238,142	12,841,536

Flusso di cassa 13

Dati annuali Flusso di cassa per ADPT
Metrica	2025	2024	2023	2022	2021	2020	2019	2018
D&A	$16M	$17M	$20M	$21M	·	·	·	·
Stock-based Comp	$51M	$54M	$63M	$55M	$43M	$25M	$13M	$11M
Amort. of Intangibles	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M
Restructuring	·	$2M	·	$2M	·	·	·	·
Operating Cash Flow	$-46M	$-95M	$-156M	$-184M	$-193M	$-150M	$205M	$-32M
CapEx	$3M	$4M	$11M	$16M	$62M	$19M	$11M	$6M
Investing Cash Flow	$38M	$78M	$130M	$3M	$181M	$-117M	$-482M	$736.0K
Stock Issued	·	·	·	·	·	$272M	$321M	·
Net Stock Activity	·	·	·	·	·	$272M	·	·
Financing Cash Flow	$30M	$241.0K	$2M	$132M	$27M	$294M	$320M	$1M
Net Change in Cash	$22M	$-17M	$-24M	$-49M	$16M	$27M	$44M	$-30M
Free Cash Flow	$-49M	$-99M	$-167M	$-200M	$-254M	$-168M	$194M	·
Levered FCF	$-61M	·	·	·	·	·	·	·

Redditività 7

Dati annuali Redditività per ADPT
Metrica	2025	2024	2023	2022	2021	2020	2019	2018
Operating Margin	-20.6%	-90.8%	-133.3%	-108.0%	-135.4%	-155.3%	-92.2%	·
Net Margin	-21.5%	-89.1%	-132.3%	-108.0%	-134.3%	-148.6%	-80.7%	·
Pretax Margin	-21.5%	-89.2%	-132.3%	-108.1%	-134.3%	·	·	·
EBITDA Margin	-20.6%	-90.8%	-133.3%	-108.0%	-135.4%	-155.3%	-92.2%	·
ROA	-11.3%	-26.6%	-29.7%	-22.5%	-20.3%	-14.4%	-11.0%	·
ROE	-28.2%	-62.4%	-58.3%	-37.5%	-30.8%	-23.0%	-11.9%	·
ROIC	-16.3%	·	·	·	·	·	·	·

Liquidità e Solvibilità 5

Dati annuali Liquidità e Solvibilità per ADPT
Metrica	2025	2024	2023	2022	2021	2020	2019	2018
Current Ratio	3.3	2.9	4.7	5.1	3.5	6.9	7.8	·
Quick Ratio	1.3	0.9	1.2	1.2	1.4	1.3	1.4	·
Debt / Equity	0.6	0.7	0.4	·	·	·	·	·
LT Debt / Equity	0.6	0.7	0.4	·	·	·	·	·
Interest Coverage	-4.8	-14.0	-16.5	-47.2	·	·	·	·

Efficienza 3

Dati annuali Efficienza per ADPT
Metrica	2025	2024	2023	2022	2021	2020	2019	2018
Asset Turnover	0.5	0.3	0.2	0.2	0.2	0.1	0.1	·
Inventory Turnover	7.8	6.3	5.2	3.4	3.0	1.9	2.6	·
Receivables Turnover	6.0	4.5	4.4	6.4	11.2	8.7	9.7	·

Per Azione 5

Dati annuali Per Azione per ADPT
Metrica	2025	2024	2023	2022	2021	2020	2019	2018
Book Value / Share	$1.42	$1.37	$2.13	$3.24	$4.27	$5.40	$4.56	·
Revenue / Share	$1.83	$1.22	$1.18	$1.30	·	·	·	·
Cash Flow / Share	$-0.30	$-0.65	$-1.08	$-1.29	·	·	·	·
Cash / Share	$0.46	$0.32	$0.45	$0.63	$0.98	$0.90	$0.77	·
EPS (TTM)	$-0.39	$-1.08	$-1.56	$-1.40	$-1.48	$-1.11	·	·

Tassi di Crescita 3

Dati annuali Tassi di Crescita per ADPT
Metrica	2025	2024	2023	2022	2021	2020	2019	2018
Revenue YoY	54.8%	5.1%	-8.1%	20.1%	56.9%	·	·	·
Revenue CAGR 3Y	14.3%	5.1%	20.1%	·	·	·	·	·
Revenue CAGR 5Y	23.0%	·	·	·	·	·	·	·

Valutazione (TTM) 14

Dati annuali Valutazione (TTM) per ADPT
Metrica	2025	2024	2023	2022	2021	2020	2019	2018
Revenue TTM	$277M	$179M	$170M	$185M	$154M	$98M	$85M	·
Net Income TTM	$-59M	$-159M	$-225M	$-200M	$-207M	$-146M	$-69M	·
Market Cap	$2.50B	$886M	$711M	$1.09B	$3.97B	$8.14B	$3.75B	·
Enterprise Value	$2.56B	$971M	$776M	·	·	·	·	·
P/E	-41.6	-5.6	-3.1	-5.5	-19.0	-53.3	·	·
P/S	9.0	5.0	4.2	5.9	25.7	82.7	44.0	·
P/B	11.4	4.4	2.3	2.4	6.6	11.0	6.6	·
P / Tangible Book	25.5	11.0	3.9	3.2	8.3	13.3	·	·
P / Cash Flow	-54.3	-9.3	-4.5	-5.9	-20.6	-54.4	18.2	·
P / FCF	-51.0	-9.0	-4.3	-5.5	-15.6	-48.3	19.3	·
EV / EBITDA	-44.8	-6.0	-3.4	·	·	·	·	·
EV / FCF	-52.3	-9.8	-4.6	·	·	·	·	·
EV / Revenue	9.2	5.4	4.6	·	·	·	·	·
Earnings Yield	-2.4%	-18.0%	-31.8%	-18.3%	-5.3%	-1.9%	·	·

Conto Economico 13

Dati trimestrali Conto Economico per ADPT
Metrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Revenue	$71M	$72M	$94M	$59M	$52M	$47M	$46M	$43M	$42M	$46M	$38M	$49M	$38M	$55M	$48M	$44M
Cost of Revenue	$19M	$18M	$18M	$18M	$17M	$18M	$17M	$19M	$18M	$20M	$19M	$18M	$19M	$17M	$15M	$13M
R&D Expense	$24M	$22M	$24M	$24M	$24M	$23M	$24M	$25M	$30M	$29M	$29M	$32M	$33M	$31M	$36M	$37M
SG&A Expense	$21M	$20M	$18M	$18M	$17M	$18M	$17M	$18M	$20M	$21M	$20M	$22M	$21M	$22M	$21M	$21M
Operating Expenses	$90M	$84M	$84M	$84M	$82M	$81M	$79M	$91M	$91M	$117M	$89M	$97M	$95M	$94M	$93M	$96M
Operating Income	$-19M	$-13M	$10M	$-25M	$-30M	$-34M	$-33M	$-47M	$-49M	$-71M	$-51M	$-48M	$-57M	$-39M	$-45M	$-53M
Interest Expense	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$4M	$4M	$4M	$4M	$653.0K	·
Net Income	$-20M	$-14M	$10M	$-26M	$-30M	$-34M	$-32M	$-46M	$-48M	$-69M	$-50M	$-48M	$-58M	$-40M	$-45M	$-52M
EPS (Basic)	$-0.13	$-0.08	$0.06	$-0.17	$-0.20	$-0.22	$-0.22	$-0.31	$-0.33	$-0.48	$-0.35	$-0.33	$-0.40	$-0.27	$-0.32	$-0.37
EPS (Diluted)	$-0.13	$-0.08	$0.06	$-0.17	$-0.20	$-0.22	$-0.22	$-0.31	$-0.33	$-0.48	$-0.35	$-0.33	$-0.40	$-0.27	$-0.32	$-0.37
Shares (Basic)	155,521,048	-301,987,680	152,432,307	152,082,284	149,195,028	-293,616,372	147,516,398	147,414,095	145,787,527	-288,230,409	144,704,868	144,397,693	143,511,142	-284,473,578	142,928,654	142,363,589
Shares (Diluted)	155,521,048	-312,717,480	163,162,107	152,082,284	149,195,028	-293,616,372	147,516,398	147,414,095	145,787,527	-288,230,409	144,704,868	144,397,693	143,511,142	-284,473,578	142,928,654	142,363,589
EBITDA	$-19M	·	$10M	$-25M	$-30M	·	$-33M	$-47M	$-49M	·	$-51M	$-48M	$-57M	·	$-45M	$-53M

Stato Patrimoniale 27

Dati trimestrali Stato Patrimoniale per ADPT
Metrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Cash & Equivalents	$78M	$70M	$55M	$43M	$51M	$48M	$38M	$60M	$71M	·	$89M	$109M	$95M	·	$218M	$76M
Receivables	$48M	$50M	$45M	$44M	$44M	$42M	$41M	$36M	$42M	·	$31M	$32M	$31M	·	$27M	$24M
Inventory	$11M	$10M	$10M	$8M	$9M	$8M	$12M	$13M	$13M	·	$19M	$19M	$20M	·	$17M	$19M
Prepaid Expense	$14M	$13M	$14M	$11M	$11M	$11M	$12M	$11M	$10M	·	$13M	$9M	$10M	·	$12M	$12M
Current Assets	$292M	$300M	$281M	$262M	$256M	$284M	$308M	$352M	$374M	·	$435M	$477M	$501M	·	$564M	$439M
PP&E (Net)	$31M	$34M	$37M	$41M	$44M	$49M	$51M	$55M	$65M	·	$77M	$79M	$81M	·	$87M	$87M
PP&E (Gross)	·	$130M	·	·	·	$136M	·	·	·	·	·	·	·	·	·	·
Accum. Depreciation	·	$96M	·	·	·	$88M	·	·	·	·	·	·	·	·	·	·
Goodwill	$119M	$119M	$119M	$119M	$119M	$119M	$119M	$119M	$119M	·	$119M	$119M	$119M	·	$119M	$119M
Intangibles	$1M	$2M	$2M	$3M	$3M	$3M	$4M	$4M	$5M	·	$6M	$6M	$6M	·	$7M	$8M
Other Non-current Assets	$1M	$1M	$2M	$2M	$2M	$2M	$3M	$3M	$3M	·	$3M	$3M	$2M	·	$2M	$778.0K
Total Assets	$506M	$513M	$491M	$497M	$511M	$539M	$559M	$585M	$620M	·	$718M	$765M	$791M	·	$884M	$807M
Accounts Payable	$10M	$6M	$10M	$7M	$6M	$7M	$7M	$10M	$12M	·	$4M	$9M	$6M	·	$4M	$3M
Accrued Liabilities	$7M	$8M	$7M	$7M	$8M	$8M	$6M	$7M	$8M	·	$10M	$8M	$8M	·	$11M	$9M
Current Liabilities	$87M	$90M	$83M	$92M	$88M	$98M	$88M	$88M	$83M	·	$93M	$95M	$90M	·	$104M	$111M
Capital Leases	$69M	$70M	$72M	$74M	$76M	$79M	$82M	$84M	$87M	·	$92M	$94M	$96M	·	$101M	$103M
Other Non-current Liabilities	$20.0K	$20.0K	$20.0K	$20.0K	$20.0K	$20.0K	$20.0K	$20.0K	·	·	·	·	·	·	·	·
Total Liabilities	$282M	$288M	$286M	$317M	$321M	$337M	$335M	$343M	$346M	·	$356M	$369M	$368M	·	$396M	$288M
Long-term Debt	$131M	$131M	$132M	$134M	$134M	$133M	·	·	·	·	$130M	·	·	·	·	·
Total Debt	$131M	·	$132M	$134M	$134M	·	$133M	$132M	$132M	·	$130M	·	·	·	·	·
Common Stock	$16.0K	$15.0K	$15.0K	$15.0K	$15.0K	$14.0K	$14.0K	$14.0K	$14.0K	·	$14.0K	$14.0K	$14.0K	·	$14.0K	$14.0K
Paid-in Capital	$1.60B	$1.58B	$1.55B	$1.54B	$1.52B	$1.51B	$1.49B	$1.48B	$1.47B	·	$1.44B	$1.42B	$1.40B	·	$1.37B	$1.36B
Retained Earnings	$-1.38B	$-1.36B	$-1.35B	$-1.36B	$-1.33B	$-1.30B	$-1.27B	$-1.24B	$-1.19B	·	$-1.07B	$-1.02B	$-977M	·	$-879M	$-834M
AOCI	$-28.0K	$253.0K	$211.0K	$73.0K	$134.0K	$166.0K	$497.0K	$-182.0K	$-106.0K	·	$-250.0K	$-893.0K	$-2M	·	$-6M	$-6M
Stockholders' Equity	$216M	$219M	$204M	$180M	$190M	$203M	$224M	$242M	$275M	·	$362M	$396M	$424M	·	$488M	$518M
Liabilities + Equity	$506M	$513M	$491M	$497M	$511M	$539M	$559M	$585M	$620M	·	$718M	$765M	$791M	·	$884M	$807M
Shares Outstanding	159,697,221	153,779,418	152,581,042	152,234,772	151,916,722	147,773,744	147,561,586	147,462,201	147,368,324	·	144,772,751	144,645,118	144,279,969	·	142,987,127	142,784,868

Flusso di cassa 10

Dati trimestrali Flusso di cassa per ADPT
Metrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
D&A	$3M	$3M	$4M	$4M	$4M	$4M	$4M	$5M	$5M	$3M	$6M	$6M	$5M	·	·	·
Stock-based Comp	$12M	$13M	$13M	$13M	$12M	$13M	$14M	$13M	$14M	$16M	$15M	$17M	$15M	$14M	$14M	$14M
Amort. of Intangibles	$419.0K	$429.0K	$428.0K	$423.0K	$419.0K	$428.0K	$428.0K	$424.0K	$423.0K	$429.0K	$428.0K	$423.0K	$419.0K	$429.0K	$428.0K	$423.0K
Restructuring	$643.0K	·	·	·	$0	$87.0K	$193.0K	$680.0K	$1M	·	·	·	·	·	·	·
Operating Cash Flow	$-10M	$2M	$-7M	$-12M	$-28M	$-12M	$-27M	$-17M	$-38M	$-27M	$-47M	$-24M	$-59M	$-30M	$-42M	$-47M
CapEx	$796.0K	$636.0K	$409.0K	$655.0K	$1M	$80.0K	$344.0K	$2M	$2M	$1M	$3M	$4M	$3M	$3M	$5M	$5M
Investing Cash Flow	$9M	$-8M	$17M	$3M	$26M	$22M	$5M	$6M	$45M	$3M	$26M	$37M	$63M	$-98M	$58M	$5M
Financing Cash Flow	$8M	$22M	$2M	$2M	$5M	$127.0K	$40.0K	$30.0K	$44.0K	$87.0K	$17.0K	$1M	$672.0K	$6.0K	$126M	$4M
Net Change in Cash	$7M	$15M	$12M	$-7M	$3M	$10M	$-22M	$-11M	$6M	$-24M	$-21M	$15M	$4M	$-128M	$141M	$-38M
Free Cash Flow	$-10M	·	·	·	$-30M	·	·	·	$-40M	·	·	·	$-62M	·	·	·

Redditività 5

Dati trimestrali Redditività per ADPT
Metrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Operating Margin	-27.1%	·	10.9%	-42.5%	-56.5%	·	-70.3%	-109.6%	-116.5%	·	-134.4%	-97.7%	-151.9%	·	-95.0%	-120.2%
Net Margin	-28.3%	·	10.2%	-43.5%	-56.9%	·	-69.1%	-107.0%	-113.5%	·	-132.7%	-97.7%	-153.3%	·	-94.7%	-119.2%
EBITDA Margin	-27.1%	·	10.9%	-42.5%	-56.5%	·	-70.3%	-109.6%	-116.5%	·	-134.4%	-97.7%	-151.9%	·	-95.0%	-120.2%
ROA	-3.9%	·	1.8%	-4.7%	-5.3%	·	-5.0%	-6.9%	-6.7%	·	-6.3%	-6.1%	-7.0%	·	-4.8%	-5.7%
ROE	-9.8%	·	4.5%	-12.2%	-12.8%	·	-10.9%	-14.5%	-13.6%	·	-11.8%	-10.5%	-11.8%	·	-8.0%	-8.6%

Liquidità e Solvibilità 5

Dati trimestrali Liquidità e Solvibilità per ADPT
Metrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Current Ratio	3.4	·	3.4	2.8	2.9	·	3.5	4.0	4.5	·	4.7	5.0	5.6	·	5.4	3.9
Quick Ratio	1.4	·	1.2	0.9	1.1	·	0.9	1.1	1.4	·	1.3	1.5	1.4	·	2.3	0.9
Debt / Equity	0.6	·	0.6	0.7	0.7	·	0.6	0.5	0.5	·	0.4	·	·	·	·	·
LT Debt / Equity	0.6	·	0.6	0.7	0.7	·	0.6	0.5	0.5	·	0.4	·	·	·	·	·
Interest Coverage	-6.6	·	3.5	-8.5	-10.2	·	-11.1	-17.6	-16.3	·	-14.0	-13.3	-16.2	·	-69.6	·

Efficienza 3

Dati trimestrali Efficienza per ADPT
Metrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Asset Turnover	0.1	·	0.2	0.1	0.1	·	0.1	0.1	0.1	·	0.0	0.1	0.0	·	0.1	0.0
Inventory Turnover	1.9	·	1.7	1.7	1.5	·	1.1	1.2	1.1	·	1.1	0.9	0.9	·	0.8	0.7
Receivables Turnover	1.5	·	2.2	1.5	1.2	·	1.3	1.3	1.1	·	1.3	1.8	1.4	·	2.2	2.3

Per Azione 5

Dati trimestrali Per Azione per ADPT
Metrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Book Value / Share	$1.35	·	$1.34	$1.18	$1.25	·	$1.52	$1.64	$1.87	·	$2.50	$2.74	$2.94	·	$3.41	$3.63
Revenue / Share	$0.46	·	$0.58	$0.39	$0.35	·	$0.31	$0.29	$0.29	·	$0.26	$0.34	$0.26	·	$0.33	$0.31
Cash Flow / Share	$-0.06	·	·	·	$-0.19	·	·	·	$-0.26	·	·	·	$-0.41	·	·	·
Cash / Share	$0.49	·	$0.36	$0.28	$0.33	·	$0.26	$0.41	$0.48	·	$0.61	$0.76	$0.66	·	$1.52	$0.54
EPS (TTM)	$-0.44	·	$-0.53	$-0.90	$-1.06	·	$-1.21	$-1.32	$-1.41	·	$-1.40	$-1.42	$-1.53	·	$-1.53	$-1.56

Valutazione (TTM) 14

Dati trimestrali Valutazione (TTM) per ADPT
Metrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Revenue TTM	$276M	·	$252M	$201M	$184M	·	$169M	$172M	$166M	·	$172M	$178M	$168M	·	$170M	$160M
Net Income TTM	$-66M	·	$-78M	$-134M	$-156M	·	$-176M	$-192M	$-203M	·	$-201M	$-203M	$-218M	·	$-216M	$-220M
Market Cap	$2.22B	·	$2.28B	$1.77B	$1.13B	·	$756M	$534M	$473M	·	$789M	$971M	$1.27B	·	$1.02B	$1.16B
Enterprise Value	$2.27B	·	$2.36B	$1.86B	$1.21B	·	$850M	$606M	$533M	·	$830M	·	·	·	·	·
P/E	-31.5	·	-28.2	-12.9	-7.0	·	-4.2	-2.7	-2.3	·	-3.9	-4.7	-5.8	·	-4.7	-5.2
P/S	8.0	·	9.1	8.8	6.1	·	4.5	3.1	2.8	·	4.6	5.5	7.6	·	6.0	7.2
P/B	10.2	·	11.2	9.9	5.9	·	3.4	2.2	1.7	·	2.2	2.5	3.0	·	2.1	2.2
P / Tangible Book	23.1	·	27.4	30.5	16.5	·	7.5	4.5	3.1	·	3.3	3.6	4.3	·	2.8	2.9
P / Cash Flow	-232.4	·	·	·	-39.6	·	·	·	-12.3	·	·	·	-21.5	·	·	·
P / FCF	-214.5	·	·	·	-37.9	·	·	·	-11.9	·	·	·	-20.5	·	·	·
EV / EBITDA	-118.2	·	229.3	-74.5	-40.9	·	-26.1	-12.8	-10.9	·	-16.3	·	·	·	·	·
EV / FCF	-219.6	·	·	·	-40.7	·	·	·	-13.4	·	·	·	·	·	·	·
EV / Revenue	8.2	·	9.4	9.3	6.6	·	5.0	3.5	3.2	·	4.8	·	·	·	·	·
Earnings Yield	-3.2%	·	-3.5%	-7.7%	-14.3%	·	-23.6%	-36.5%	-43.9%	·	-25.7%	-21.2%	-17.3%	·	-21.5%	-19.3%

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Conto Economico

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Ricavi	$277M	$179M	$170M	$185M	$154M
Margine Operativo %	-20.6%	-90.8%	-133.3%	-108.0%	-135.4%
Utile netto	$-59M	$-159M	$-225M	$-200M	$-207M
EPS Diluito	$-0.39	$-1.08	$-1.56	$-1.40	$-1.48

Stato Patrimoniale

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Debito / Patrimonio Netto	0.6	0.7	0.4	—	—
Rapporto corrente	3.3	2.9	4.7	5.1	3.5
Quick Ratio	1.3	0.9	1.2	1.2	1.4

Flusso di cassa

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flusso di cassa libero	$-49M	$-99M	$-167M	$-200M	$-254M

Ultime notizie Notizie recenti che menzionano questa società

Il Chief Operating Officer di Adaptive Biotechnologies ha venduto oltre 19.000 azioni della società. Ecco cosa significa per gli investitori. Nasdaq · 2 settimane, 2 giorni fa

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

📊

Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

ADPT Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

ADPT Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Medie mobili e sovrapposizioni

Volume

Oscillatori

Momentum e tendenza

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

ADPT Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

Target Price a 12 Mesi

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Confronto tra pari Metriche chiave rispetto ai pari del settore

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Ultime notizie Notizie recenti che menzionano questa società

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi